Maravai LifeSciences Holdings

MRVI · NASDAQ

$7.20+$0.21 (+3.00%)TodayMarket closed · Oct 20, 7:50 PM ET

Prev close $6.99

Latest news

Press releaseOct 14, 4:01 PM ETBusiness Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
NewsOct 13, 4:58 AM ET
Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call
Press releaseSep 29, 4:01 PM ETBusiness Wire
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP
NewsAug 20, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Press releaseAug 6, 4:01 PM ETBusiness Wire
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
Press releaseJul 22, 4:02 PM ETBusiness Wire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Press releaseJul 20, 4:02 PM ETBusiness Wire
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
Press releaseJun 16, 8:30 AM ETBusiness Wire
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
Press releaseJun 3, 8:30 AM ETBusiness Wire
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
Press releaseMay 18, 4:00 PM ETBusiness Wire
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
NewsMay 8, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMay 7, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 7, 4:03 PM ET
Maravai LifeSciences Q1 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $65.837M Beat $53.046M Estimate
Press releaseMay 7, 4:01 PM ETBusiness Wire
Maravai LifeSciences Reports First Quarter 2026 Financial Results
Press releaseApr 20, 4:05 PM ETBusiness Wire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
Press releaseFeb 25, 4:01 PM ETBusiness Wire
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
Press releaseFeb 9, 5:05 PM ETBusiness Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
Press releaseNov 10, 8:00 AM ETBusiness Wire
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
Press releaseNov 6, 4:01 PM ETBusiness Wire
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
Press releaseOct 29, 7:52 AM ETGlobe Newswire
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
Press releaseOct 22, 4:01 PM ETBusiness Wire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
Press releaseOct 2, 7:42 AM ETGlobe Newswire
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseSep 9, 5:17 PM ETGlobe Newswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 11, 4:05 PM ETGlobe Newswire
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
NewsAug 8, 3:07 PM ET
What to Expect from Maravai LifeSciences's Earnings
Press releaseJul 25, 6:44 PM ETBusiness Wire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
Press releaseJul 22, 7:27 PM ETGlobe Newswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseJul 11, 10:13 PM ETPRNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
Press releaseJul 8, 9:00 PM ETGlobe Newswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseJun 27, 6:37 PM ETBusiness Wire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
Press releaseJun 24, 9:00 PM ETGlobe Newswire
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseJun 3, 10:00 AM ETBusiness Wire
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
Press releaseMay 12, 4:06 PM ETGlobe Newswire
Maravai Lifesciences Reports First Quarter 2025 Financial Results
Press releaseMar 18, 4:05 PM ETGlobe Newswire
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
Press releaseNov 7, 4:01 PM ETGlobe Newswire
Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026

Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call

TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

12 Health Care Stocks Moving In Thursday's Intraday Session

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026

TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology

TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale

Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032

Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Maravai LifeSciences Q1 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $65.837M Beat $53.046M Estimate

Maravai LifeSciences Reports First Quarter 2026 Financial Results

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 6, 2025

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

What to Expect from Maravai LifeSciences's Earnings

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

Maravai Lifesciences Reports First Quarter 2025 Financial Results

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Maravai LifeSciences Reports Third Quarter 2024 Financial Results